{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:45:20Z","timestamp":1760013920892,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["320360","320360","320360"],"award-info":[{"award-number":["320360","320360","320360"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NTNU Norwegian University of Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>One measure to support optimal opioid prescription is academic detailing (AD) with one-to-one visits by trained professionals (academic detailers) to general practitioners (GPs).<\/jats:p>\n                <jats:p>Objective: To investigate the usefulness of AD visits on GPs\u2019 opioid prescribing patterns in Norway, and academic detailers\u2019 experiences with AD visits to GPs on opioid prescription.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Design: A quantitative registry study on opioid prescriptions and a qualitative focus group interview study with academic detailers.<\/jats:p>\n                <jats:p>Participants: For the registry study, municipalities where more than 75% of the GPs had received an AD visit were considered intervention municipalities, whereas in the non-intervention municipalities no GPs had received AD-visits. In the focus groups, academic detailers who had conducted three or more AD-visits were invited to participate.<\/jats:p>\n                <jats:p>Intervention: A campaign on opioid prescription with AD visits using a brochure with key messages based on the national guideline for treatment of chronic non-cancer pain and updated evidence on the potential benefits and risks of prescribing opioids. The AD visits in the campaign were planned for 20\u201325\u00a0min in a one-to-one setting in the GP\u2019s office.<\/jats:p>\n                <jats:p>Main Measures: The Norwegian Prescription Database (NorPD) was utilized for registry data. Data on amount of drugs dispensed are recoded as Defined Daily Doses (DDDs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to non-intervention, the intervention resulted in a decrease in the number of prevalent and incident users of opioids and incident users of reimbursed opioids for chronic non-cancer pain in municipalities in Central Norway. The results from the focus group interviews were categorized into the themes: \u201cTo get in position\u201d, \u201cAdjusting messages\u201d, \u201cWhat did the GPs struggle with, in relation to opioid prescription?\u201d and \u201cDid we reach the right recipients with the visits?\u201d.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In Central Norway, the intervention resulted in a desired effect on number of opioid users. According to the academic detailers, the GPs\u2019 length of working experience and familiarity with the topic gave different presumptions for making use of the information presented in the AD-visits.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02040-6","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T16:04:09Z","timestamp":1679933049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Can academic detailing reduce opioid prescriptions in chronic non-cancer pain?"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3566-3328","authenticated-orcid":false,"given":"Ketil Arne","family":"Espnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torunn Hatlen","family":"N\u00f8st","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marte","family":"Handal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana O.","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald C.","family":"Langaas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"issue":"10028","key":"2040_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(16)00161-6.","journal-title":"Lancet"},{"key":"2040_CR2","doi-asserted-by":"publisher","first-page":"109281","DOI":"10.1016\/j.drugalcdep.2022.109281","volume":"232","author":"HME Edvardsen","year":"2022","unstructured":"Edvardsen HME, Clausen T. Opioid related deaths in Norway in 2000\u20132019 [published online ahead of print, 2022 Jan 12]. Drug Alcohol Depend. 2022;232:109281. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109281.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2040_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.amepre.2019.09.022","volume":"58","author":"AB Abbasi","year":"2020","unstructured":"Abbasi AB, Salisbury-Afshar E, Berberet CE, Layden JE, Pho MT. Opioid Prescribing Patterns Before Fatal Opioid Overdose. Am J Prev Med. 2020;58(2):250\u20133. https:\/\/doi.org\/10.1016\/j.amepre.2019.09.022.","journal-title":"Am J Prev Med"},{"issue":"10324","key":"2040_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(21)02252-2","volume":"399","author":"K Humphreys","year":"2022","unstructured":"Humphreys K, Shover CL, Andrews CM, et al. Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission. Lancet. 2022;399(10324):555\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(21)02252-2.","journal-title":"Lancet"},{"issue":"10","key":"2040_CR5","doi-asserted-by":"publisher","first-page":"CD012509","DOI":"10.1002\/14651858.CD012509.pub2","volume":"10","author":"C Els","year":"2017","unstructured":"Els C, Jackson TD, Kunyk D, et al. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2017;10(10):CD012509. https:\/\/doi.org\/10.1002\/14651858.CD012509.pub2. (Published 2017 Oct 30).","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"2040_CR6","first-page":"9","volume":"17","author":"M Schiltenwolf","year":"2014","unstructured":"Schiltenwolf M, Akbar M, Hug A, et al. Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids. Pain Physician. 2014;17(1):9\u201320.","journal-title":"Pain Physician"},{"issue":"12","key":"2040_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11912-016-0558-1","volume":"18","author":"MP Davis","year":"2016","unstructured":"Davis MP, Mehta Z. Opioids and Chronic Pain: Where Is the Balance? Curr Oncol Rep. 2016;18(12):71. https:\/\/doi.org\/10.1007\/s11912-016-0558-1.","journal-title":"Curr Oncol Rep"},{"issue":"23","key":"2040_CR8","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","volume":"320","author":"JW Busse","year":"2018","unstructured":"Busse JW, Wang L, Kamaleldin M, et al. Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis. JAMA. 2018;320(23):2448\u201360. https:\/\/doi.org\/10.1001\/jama.2018.18472.","journal-title":"JAMA"},{"issue":"24","key":"2040_CR9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","volume":"308","author":"J Avorn","year":"1983","unstructured":"Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based \u201cdetailing.\u201d N Engl J Med. 1983;308(24):1457\u201363. https:\/\/doi.org\/10.1056\/NEJM198306163082406.","journal-title":"N Engl J Med."},{"key":"2040_CR10","doi-asserted-by":"publisher","unstructured":"O\u2019Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis D, Haynes RB, Harvey E. Educational outreach visits: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007(4):CD000409. https:\/\/doi.org\/10.1002\/14651858.CD000409.pub2.","DOI":"10.1002\/14651858.CD000409.pub2"},{"issue":"2S","key":"2040_CR11","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.36076\/ppj.2017.s151","volume":"20","author":"M Trotter Davis","year":"2017","unstructured":"Trotter Davis M, Bateman B, Avorn J. Educational Outreach to Opioid Prescribers: The Case for Academic Detailing. Pain Physician. 2017;20(2S):S147\u201351.","journal-title":"Pain Physician"},{"issue":"6","key":"2040_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.japh.2020.08.011","volume":"60","author":"CD Saffore","year":"2020","unstructured":"Saffore CD, Pickard AS, Crawford SY, Fischer MA, Sharp LK, Lee TA. Practice change intentions after academic detailing align with subsequent opioid prescribing. J Am Pharm Assoc (2003). 2020;60(6):1001\u20138. https:\/\/doi.org\/10.1016\/j.japh.2020.08.011.","journal-title":"J Am Pharm Assoc (2003)."},{"issue":"10","key":"2040_CR13","doi-asserted-by":"publisher","first-page":"e1003796","DOI":"10.1371\/journal.pmed.1003796","volume":"18","author":"SL Alderson","year":"2021","unstructured":"Alderson SL, Farragher TM, Willis TA, Carder P, Johnson S, Foy R. The effects of an evidence- and theory-informed feedback intervention on opioid prescribing for non-cancer pain in primary care: A controlled interrupted time series analysis. PLoS Med. 2021;18(10):e1003796. https:\/\/doi.org\/10.1371\/journal.pmed.1003796. (Published 2021 Oct 4).","journal-title":"PLoS Med."},{"issue":"1","key":"2040_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13012-017-0602-z","volume":"12","author":"L Desveaux","year":"2017","unstructured":"Desveaux L, Saragosa M, Rogers J, et al. Improving the appropriateness of antipsychotic prescribing in nursing homes: a mixed-methods process evaluation of an academic detailing intervention. Implement Sci. 2017;12(1):71. https:\/\/doi.org\/10.1186\/s13012-017-0602-z. (Published 2017 May 26).","journal-title":"Implement Sci."},{"issue":"1","key":"2040_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13012-019-0853-y","volume":"14","author":"RC Gale","year":"2019","unstructured":"Gale RC, Wu J, Erhardt T, et al. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci. 2019;14(1):11. https:\/\/doi.org\/10.1186\/s13012-019-0853-y. (Published 2019 Feb 1).","journal-title":"Implement Sci."},{"issue":"suppl_1","key":"2040_CR16","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1093\/pm\/pny085","volume":"19","author":"AM Midboe","year":"2018","unstructured":"Midboe AM, Wu J, Erhardt T, et al. Academic Detailing to Improve Opioid Safety: Implementation Lessons from a Qualitative Evaluation. Pain Med. 2018;19(suppl_1):S46\u201353. https:\/\/doi.org\/10.1093\/pm\/pny085.","journal-title":"Pain Med."},{"issue":"4","key":"2040_CR17","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s00228-018-02611-y","volume":"75","author":"HC Langaas","year":"2019","unstructured":"Langaas HC, Hurley E, Dyrkorn R, Spigset O. Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2019;75(4):577\u201386. https:\/\/doi.org\/10.1007\/s00228-018-02611-y.","journal-title":"Eur J Clin Pharmacol"},{"key":"2040_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/AMEP.S206073","volume":"10","author":"R Dyrkorn","year":"2019","unstructured":"Dyrkorn R, Langaas HC, Giverhaug T, Espnes KA, Rowett D, Spigset O. Academic detailing as a method of continuing medical education. Adv Med Educ Pract. 2019;10:717\u201325. https:\/\/doi.org\/10.2147\/AMEP.S206073. (Published 2019 Aug 30).","journal-title":"Adv Med Educ Pract."},{"key":"2040_CR19","unstructured":"About RELIS (https:\/\/relis.no\/about_relis). Accessed: February 21st, 2022."},{"key":"2040_CR20","unstructured":"The Norwegian Directorate of Health. Nasjonal veileder for bruk av opioider ved langvarige ikke-kreftrelaterte smerter. 2015. Retrieved from https:\/\/www.legeforeningen.no\/contentassets\/05dc17c74d5a4dfa87d9046d9ca5e48c\/utkast-veileder-bruk-avopioider-ved-langvarige-ikke-kreftrelaterte-smerter.pdf. Accessed 21 Feb 2022."},{"issue":"4","key":"2040_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1001\/jama.2016.16036","volume":"317","author":"J Avorn","year":"2017","unstructured":"Avorn J. Academic Detailing: \u201cMarketing\u201d the Best Evidence to Clinicians. JAMA. 2017;317(4):361\u20132. https:\/\/doi.org\/10.1001\/jama.2016.16036. (PMID: 28118458).","journal-title":"JAMA"},{"key":"2040_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-981-15-2333-5_4","volume-title":"Improving Use of Medicines and Medical Tests in Primary Care","author":"D Rowett","year":"2020","unstructured":"Rowett D. Evidence for and Implementation of Academic Detailing. In Improving Use of Medicines and Medical Tests in Primary Care. Edited by Weekes LM. Singapore, Springer Singapore; 2020:83\u2013105."},{"key":"2040_CR23","unstructured":"Norwegian Institute of Public Health. Welcome to the Norwegian Prescription Database. Retrieved from https:\/\/www.norpd.no\/default.aspx. Accessed 21 Feb 2022."},{"key":"2040_CR24","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. The ATC\/DDD Index. Retrieved from: https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 21 Feb 2022."},{"issue":"8","key":"2040_CR25","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/1403494812465030","volume":"40","author":"K Malterud","year":"2012","unstructured":"Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40(8):795\u2013805. https:\/\/doi.org\/10.1177\/1403494812465030.","journal-title":"Scand J Public Health"},{"key":"2040_CR26","doi-asserted-by":"publisher","unstructured":"Skurtveit S, Hjellvik V, Sakshaug S, et al. Forskrivning av opioider p\u00e5 bl\u00e5 resept mot langvarige smerter [Prescribing of opioids for chronic pain on reimbursable prescription].\u00a0Tidsskr Nor Laegeforen. 2020;140(15). https:\/\/doi.org\/10.4045\/tidsskr.20.0153. Published 2020 Oct 19.","DOI":"10.4045\/tidsskr.20.0153"},{"issue":"2","key":"2040_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/sjpain-2018-0307","volume":"19","author":"AE Muller","year":"2019","unstructured":"Muller AE, Clausen T, Sj\u00f8gren P, Odsbu I, Skurtveit S. Prescribed opioid analgesic use developments in three Nordic countries, 2006\u20132017. Scand J Pain. 2019;19(2):345\u201353. https:\/\/doi.org\/10.1515\/sjpain-2018-0307.","journal-title":"Scand J Pain"},{"key":"2040_CR28","unstructured":"Norwegian Institute of Public Health. Langvarig smerte i Norge. Retrieved from:\u00a0\nhttps:\/\/www.fhi.no\/nettpub\/hin\/ikke-smittsomme\/smerte\/. Accessed 21 Feb 2022."},{"issue":"15","key":"2040_CR29","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016. JAMA. 2016;315(15):1624\u201345. https:\/\/doi.org\/10.1001\/jama.2016.1464.","journal-title":"JAMA"},{"issue":"19","key":"2040_CR30","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1001\/jama.2019.16409","volume":"322","author":"D Dowell","year":"2019","unstructured":"Dowell D, Compton WM, Giroir BP. Patient-Centered Reduction or Discontinuation of Long-term Opioid Analgesics: The HHS Guide for Clinicians. JAMA. 2019;322(19):1855\u20136. https:\/\/doi.org\/10.1001\/jama.2019.16409.","journal-title":"JAMA"},{"key":"2040_CR31","unstructured":"The Norwegian Directorate of Health. Nasjonal faglig veileder - Vanedannende legemidler. Retrieved from: https:\/\/www.helsedirektoratet.no\/veiledere\/vanedannende-legemidler. Accessed 21 Feb 2022."}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02040-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02040-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T16:04:34Z","timestamp":1679933074000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02040-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2040"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02040-6","relation":{},"ISSN":["2731-4553"],"issn-type":[{"type":"electronic","value":"2731-4553"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"18 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research complies with all the relevant national regulations, institutional policies and was performed in accordance with the tenets of the Helsinki Declaration. The quantitative study used anonymized data from a national public database, no specific ethical approval was necessary according to Norwegian legislation. Approval for the qualitative study was obtained from the data protection officer, the Norwegian Social Science Data Services, NSD (318944). All informants signed an informed consent form after having received written information to enable them to make an informed choice regarding participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}